NCT05292989 A Personalised Approach Utilising the Frailty Index to Empower Consumers
| NCT ID | NCT05292989 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Princess Alexandra Hospital, Brisbane, Australia |
| Condition | Gastrointestinal Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-08-14 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-08-14 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Frailty is a common clinical syndrome in older adults that may carry an increased risk for poor health outcomes including falls, hospitalisation, and mortality. Having a colonoscopy can be associated with potential adverse outcomes in frail patients. At present, however, frailty is not routinely assessed in gastroenterological clinical practice. In a prospective randomised controlled study consenting patients over 65 years at the Princess Alexandra Hospital will receive either a) personalised (tailored) approach that includes assessment of frailty and structured information provided to the consumer or b) current standard practice in regards to having a surveillance colonoscopy to determine the effects on patient satisfaction and percentage of colonoscopies avoided.
Eligibility Criteria
Inclusion Criteria: * Patients aged over 65 years of age * Ability to understand the study instructions and answering questionnaires Exclusion Criteria: * Inability to consent or participate in the assessments (e.g. frailty assessment) that are required as part of this project. * Lack of informed consent
Frequently Asked Questions
Who can join the NCT05292989 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 100 Years, studying Gastrointestinal Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05292989 currently recruiting?
Yes, NCT05292989 is actively recruiting participants. Visit ClinicalTrials.gov or contact Princess Alexandra Hospital, Brisbane, Australia to inquire about joining.
Where is the NCT05292989 trial being conducted?
This trial is being conducted at Woolloongabba, Australia.
Who is sponsoring the NCT05292989 clinical trial?
NCT05292989 is sponsored by Princess Alexandra Hospital, Brisbane, Australia. The trial plans to enroll 200 participants.